COVID-19 Vaccine Boosters in People With Multiple Sclerosis

Overview of attention for article published in Neurology: Neuroimmunology and Neuroinflammation, July 2025

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

twitter: 14 X users

bluesky: 13 Bluesky users

Readers on

mendeley: 5 Mendeley

So far, Altmetric has seen 14 X posts from 14 X users, with an upper bound of 70,519 followers.

RT @BigBadDenis: Study: COVID-19 Vaccine Boosters in People With Multiple Sclerosis. Improved SARS-CoV-2 Cross-Variant Antibody Response a…

Study: COVID-19 Vaccine Boosters in People With Multiple Sclerosis. Improved SARS-CoV-2 Cross-Variant Antibody Response and Prediction of Protection. https://t.co/m2hEwjJN2b

"...our study...highlights need for additional #vaccine doses to improve longevity & cross-variant breadth of immune response in pw #MS on #DMT. Statistical learning–based models can help predict vaccine effectiveness against...infection/reinfection w…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 10 additional X posts.